Hypertrophic cardiomyopathy: etiology, diagnosis, and treatment. Cardiology in review [Cardiol Rev] Journal article | | Title | Hypertrophic cardiomyopathy: etiology, diagnosis, and treatment. | | Author(s) | Ramaraj R | | Institution | Department of Internal Medicine, University of Arizona College of Medicine, Tucson, Arizona 85724, USA. drkutty2@gmail.com | | Source | Cardiol Rev 2008 Jul-Aug; 16(4):172-80. | | Abstract | Hypertrophic cardiomyopathy (HCM) is a disease characterized by primary hypertrophy of the left (and sometimes right) ventricle. The clinical manifestations of the disease are dyspnea, angina, and a continuum encompassing lightheadedness, presyncope, syncope, and sudden death. Although HCM is often caused by an identifiable mutation in a gene coding for a sarcomeric protein and inherited in an autosomal-dominant pattern, many patients do not have any relatives in whom the disease is manifest. The prevalence of HCM is estimated to be 0.2%, with nearly 600,000 Americans affected. This limited exposure of clinicians to HCM understandably accounts for the uncertainty that prevails regarding this disease and its management. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 18562807 |
|
|
| |
Advertise on this site.
| | |
|
